Jiarui Zhu

2PUBLICATIONS
1CO-AUTHORS
Molecular medicineAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 07, 2026
Nerandomilast alleviates myositis-associated interstitial lung disease by modulating the non-Smad signalling pathway and activating the cAMP-PKA-RhoA pathway.

|Feb 15, 2026
Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transition.

Jumei Yang, Hui Chai, Jiarui Zhu

Pageof 1

Frequent Collaborators

2 joint publications

Sigong Zhang